nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02
|
Necchi, Andrea |
|
|
40 |
1 |
p. 10.e1-10.e6 |
artikel |
2 |
Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: a systematic review and meta-analysis
|
Zhou, Xinyi |
|
|
40 |
1 |
p. 12.e13-12.e22 |
artikel |
3 |
Anterior and apical samplings during transperineal image-guided prostate biopsy
|
Savin, Ziv |
|
|
40 |
1 |
p. 5.e15-5.e21 |
artikel |
4 |
Assessing the diagnostic performance of systematic freehand PrecisionPoint transperineal prostate biopsy: Comparison of observed outcomes to PBCG nomogram predictions
|
Setia, Shaan |
|
|
40 |
1 |
p. 4.e9-4.e17 |
artikel |
5 |
Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen
|
Eyrich, Nicholas W. |
|
|
40 |
1 |
p. 4.e1-4.e7 |
artikel |
6 |
Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)
|
Velaer, Kyla |
|
|
40 |
1 |
p. 12.e23-12.e30 |
artikel |
7 |
Collecting duct carcinoma: A single‐institution retrospective study
|
Xie, Zhuoer |
|
|
40 |
1 |
p. 13.e9-13.e18 |
artikel |
8 |
Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities
|
Yamada, Shuhei |
|
|
40 |
1 |
p. 11.e17-11.e25 |
artikel |
9 |
Cover 2 - Masthead
|
|
|
|
40 |
1 |
p. IFC |
artikel |
10 |
Critical shortage in BCG immunotherapy: How did we get here and where will it take us?
|
Harvey, Michael |
|
|
40 |
1 |
p. 1-3 |
artikel |
11 |
Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy
|
Kukreja, Janet Baack |
|
|
40 |
1 |
p. 9.e19-9.e27 |
artikel |
12 |
Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatment
|
Spek, Annabel |
|
|
40 |
1 |
p. 13.e1-13.e8 |
artikel |
13 |
Efficacy and safety of bipolar androgen therapy in mCRPC after progression on abiraterone or enzalutamide: A systematic review
|
Xiong, Xingyu |
|
|
40 |
1 |
p. 4.e19-4.e28 |
artikel |
14 |
Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors in patients with renal cell carcinoma
|
Kikuchi, Hiroshi |
|
|
40 |
1 |
p. 13.e19-13.e27 |
artikel |
15 |
Evaluating health-related quality of life as a prognostic tool for overall survival in routine cancer care for older patients with bladder cancer: A US based study
|
Pandit, Ambrish A. |
|
|
40 |
1 |
p. 11.e1-11.e8 |
artikel |
16 |
How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses
|
Erdem, Selcuk |
|
|
40 |
1 |
p. 6.e1-6.e9 |
artikel |
17 |
Impact of clinical and pathological subtypes of carcinoma in situ (CIS) of the bladder: Lessons learned from long-term follow-up of a series of CIS patients treated with BCG
|
Subiela, José Daniel |
|
|
40 |
1 |
p. 9.e9-9.e17 |
artikel |
18 |
Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG
|
Steinberg, Ryan L. |
|
|
40 |
1 |
p. 9.e1-9.e7 |
artikel |
19 |
Low conflict and high satisfaction: Decisional outcomes after attending a combined clinic to choose between robotic prostatectomy and radiotherapy for prostate cancer
|
Smith, Allan ‘Ben’ |
|
|
40 |
1 |
p. 8.e1-8.e9 |
artikel |
20 |
Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer
|
Williams, Stephen B. |
|
|
40 |
1 |
p. 10.e7-10.e12 |
artikel |
21 |
Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer
|
Nientiedt, Cathleen |
|
|
40 |
1 |
p. 8.e11-8.e18 |
artikel |
22 |
Number of cores needed to diagnose prostate cancer during MRI targeted biopsy decreases after the learning curve
|
Bevill, Mark D. |
|
|
40 |
1 |
p. 7.e19-7.e24 |
artikel |
23 |
Oncofid-P-B: a novel treatment for BCG unresponsive carcinoma in situ (CIS) of the bladder: Results of a prospective European Multicentre study at 15 months from treatment start
|
Hurle, Rodolfo |
|
|
40 |
1 |
p. 11.e9-11.e15 |
artikel |
24 |
Plasmacytoid urothelial carcinoma (UC) are luminal tumors with similar CD8+ Tcell density and PD-L1 protein expression on immune cells as compared to conventional UC
|
Kossaï, Myriam |
|
|
40 |
1 |
p. 12.e1-12.e11 |
artikel |
25 |
PSMA PET predicts metastasis-free survival in the setting of salvage radiotherapy after radical prostatectomy
|
Wenzel, Mike |
|
|
40 |
1 |
p. 7.e1-7.e8 |
artikel |
26 |
Radium-223 in patients with prostate specific antigen (PSA) progression and without clinical metastases following maximal local therapy: A pilot study
|
Tosco, Lorenzo |
|
|
40 |
1 |
p. 7.e9-7.e17 |
artikel |
27 |
Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study
|
Kim, Do Kyung |
|
|
40 |
1 |
p. 6.e11-6.e19 |
artikel |
28 |
Subpathologies and genomic classifier for treatment individualization of post-prostatectomy radiotherapy
|
Ramotar, Matthew |
|
|
40 |
1 |
p. 5.e1-5.e13 |
artikel |
29 |
Survival outcomes following radical cystectomy in patients with prior pelvic radiation for prostate cancer: A matched cohort analysis
|
Murthy, Prithvi B. |
|
|
40 |
1 |
p. 10.e13-10.e19 |
artikel |
30 |
The risk of death from prostate cancer in men with Gleason score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy
|
Yang, David D. |
|
|
40 |
1 |
p. 6.e21-6.e27 |
artikel |